Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy

doi:10.3748/wjg.v22.i13.3516

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13711)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

1320

WORD

368

HTML

7889

Figures (1-6)

1300

Tables (1-2)

258

Sum=11135

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1132

Download

1444

Sum=2576

Apr 7, 2016 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (31)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Apr 7, 2016; 22(13): 3516-3530
Published online Apr 7, 2016. doi: 10.3748/wjg.v22.i13.3516

Full Size Figure Download Figure

Figure 6 Polyp features according to location. Half of serrated adenocarcinomas (SACs) are located on the right colon. KRAS-mutated polyps are preferentially left-sided. However, polyps with BRAF mutations dominate those found on the right side of the colon. TSA: Traditional serrated adenoma; SSA: Sessile serrated adenoma.

Citation: Murcia O, Juárez M, Hernández-Illán E, Egoavil C, Giner-Calabuig M, Rodríguez-Soler M, Jover R. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy. World J Gastroenterol 2016; 22(13): 3516-3530
URL: https://www.wjgnet.com/1007-9327/full/v22/i13/3516.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i13.3516